Goodwill in USD of Orgenesis Inc. from Q4 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Orgenesis Inc. quarterly Goodwill history and change rate from Q4 2014 to Q3 2024.
  • Orgenesis Inc. Goodwill for the quarter ending 30 Sep 2024 was $1,211,000, unchanged year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

Orgenesis Inc. Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $1,211,000 $0 0% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $1,211,000 $0 0% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $1,211,000 -$6,858,000 -85% 31 Mar 2024 10-Q 20 May 2024 2024 Q1
Q4 2023 $1,211,000 -$6,976,000 -85% 31 Dec 2023 10-Q 13 Nov 2024 2024 Q3
Q3 2023 $1,211,000 -$6,553,000 -84% 30 Sep 2023 10-Q/A 15 Apr 2024 2023 Q3
Q2 2023 $1,211,000 -$6,963,000 -85% 30 Jun 2023 10-Q/A 15 Apr 2024 2023 Q2
Q1 2023 $8,069,000 -$260,000 -3.1% 31 Mar 2023 10-Q/A 15 Apr 2024 2023 Q1
Q4 2022 $8,187,000 -$216,000 -2.6% 31 Dec 2022 10-K 15 Apr 2024 2023 FY
Q3 2022 $7,764,000 -$650,000 -7.7% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $8,174,000 -$425,000 -4.9% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $8,329,000 -$273,000 -3.2% 31 Mar 2022 10-Q 23 May 2022 2022 Q1
Q4 2021 $8,403,000 -$342,000 -3.9% 31 Dec 2021 10-K 15 Apr 2024 2023 FY
Q3 2021 $8,414,000 +$3,651,000 +77% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $8,599,000 +$3,941,000 +85% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $8,602,000 +$4,010,000 +87% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $8,745,000 +$3,933,000 +82% 31 Dec 2020 10-K 22 Mar 2023 2022 FY
Q3 2020 $4,763,000 -$9,726,000 -67% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $4,658,000 -$10,408,000 -69% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $4,592,000 -$10,410,000 -69% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $4,812,000 -$130,000 -2.6% 31 Dec 2019 10-K 30 Mar 2022 2021 FY
Q3 2019 $14,489,000 -$1,143,000 -7.3% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $15,066,000 +$4,517,000 +43% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $15,002,000 +$3,989,000 +36% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 $4,942,000 -$5,742,000 -54% 31 Dec 2018 10-K 09 Mar 2021 2020 FY
Q3 2018 $15,632,000 +$4,949,000 +46% 31 Aug 2018 10-Q 12 Oct 2018 2018 Q3
Q2 2018 $10,549,000 +$501,000 +5% 31 May 2018 10-Q 17 Jul 2018 2018 Q2
Q1 2018 $11,013,000 +$1,456,000 +15% 28 Feb 2018 10-Q 16 Apr 2018 2018 Q1
Q4 2017 $10,684,000 +$1,100,000 +11% 30 Nov 2017 10-K 09 Mar 2020 2019 FY
Q3 2017 $10,683,000 +$10,672,951 31 Aug 2017 10-Q 16 Oct 2017 2017 Q3
Q2 2017 $10,048,000 +$10,037,941 31 May 2017 10-Q 24 Jul 2017 2017 Q2
Q1 2017 $9,557,000 -$255,000 -2.6% 28 Feb 2017 10-Q 19 Apr 2017 2017 Q1
Q4 2016 $9,584,000 +$49,000 +0.51% 30 Nov 2016 10-K 13 Feb 2019 2018 FY
Q3 2016 $10,049* -$10,092,711 31 Aug 2016 10-Q 14 Oct 2016 2016 Q3
Q2 2016 $10,059* -$9,876,842 31 May 2016 10-Q 15 Jul 2016 2016 Q2
Q1 2016 $9,812,000 29 Feb 2016 10-Q 14 Apr 2016 2016 Q1
Q4 2015 $9,535,000 +$9,535,000 30 Nov 2015 10-K 28 Feb 2017 2016 FY
Q3 2015 $10,102,760 31 Aug 2015 10-Q 15 Oct 2015 2015 Q3
Q2 2015 $9,886,901 31 May 2015 10-Q 15 Jul 2015 2015 Q2
Q4 2014 $0 30 Nov 2014 10-K 29 Feb 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.